Access the full text.
Sign up today, get DeepDyve free for 14 days.
Jae‐Hwan Lee, Hyun-Sook Kim, Seung‐Whan Lee, Jae‐Hyeong Park, Si-Wan Choi, J. Jeong, Y. Cho, N. Lee, K. Rhee, J. Ko, I. Seong (2008)
Prospective randomized comparison of sirolimus‐ versus paclitaxel‐eluting stents for the treatment of acute ST‐elevation myocardial infarctionCatheterization and Cardiovascular Interventions, 72
M. Hong, G. Mintz, Cheol-Whan Lee, Young-Hak Kim, Seung‐Whan Lee, Jong-Min Song, K. Han, D. Kang, Jae-Kwan Song, Jae‐Joong Kim, Seong-Wook Park, Seung‐Jung Park (2004)
Incidence, Mechanism, Predictors, and Long-Term Prognosis of Late Stent Malapposition After Bare-Metal Stent ImplantationCirculation: Journal of the American Heart Association, 109
Sousa, R. Falotico, Judith Jaeger, J. Popma, P. Serruys, S. Abizaid, L. Tanajura, K. Kozuma, G. Langenhove, R. AmandaG.M., J. Sousa, M. Costa, A. Abizaid, B. Rensing (2001)
Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting Stents: One-Year Angiographic and Intravascular Ultrasound Follow-UpCirculation: Journal of the American Heart Association, 104
A. Dibra, A. Kastrati, J. Mehilli, J. Pache, H. Schühlen, N. Beckerath, K. Ulm, R. Wessely, J. Dirschinger, A. Schömig (2005)
Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.The New England journal of medicine, 353 7
A. Schömig, A. Dibra, S. Windecker, J. Mehilli, J. Lezo, C. Kaiser, Seung‐Jung Park, J. Goy, Jae‐Hwan Lee, E. Lorenzo, Jinjin Wu, P. Jüni, M. Pfisterer, B. Meier, A. Kastrati (2007)
A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.Journal of the American College of Cardiology, 50 14
D. Kandzari, M. Leon, J. Popma, P. Fitzgerald, C. O'shaughnessy, M. Ball, M. Turco, R. Applegate, P. Gurbel, M. Midei, Sejal Badre, L. Mauri, Kweli Thompson, L. Lenarz, R. Kuntz (2006)
Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial.Journal of the American College of Cardiology, 48 12
G. Stone, J. Moses, S. Ellis, J. Schofer, K. Dawkins, M. Morice, A. Colombo, E. Schampaert, E. Grube, A. Kirtane, D. Cutlip, M. Fahy, S. Pocock, R. Mehran, M. Leon (2007)
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.The New England journal of medicine, 356 10
J. Mehilli, A. Dibra, A. Kastrati, J. Pache, J. Dirschinger, A. Schömig (2006)
Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels.European heart journal, 27 3
A. Kastrati, J. Mehilli, N. Beckerath, A. Dibra, J. Hausleiter, J. Pache, H. Schühlen, C. Schmitt, J. Dirschinger, A. Schömig (2005)
Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.JAMA, 293 2
A. Khattab, G. Richardt, Vitali Verin, H. Kelbaek, C. Macaya, J. Berland, Karine Miquel‐Hébert, C. Dorange, P. Serruys (2008)
Differentiated analysis of an everolimus-eluting stent and a paclitaxel-eluting stent among higher risk subgroups for restenosis: results from the SPIRIT II trial.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 3 5
F. Tomai, B. Reimers, L. Luca, A. Galassi, A. Gaspardone, A. Ghini, V. Ferrero, L. Favero, G. Gioffrè, F. Prati, C. Tamburino, F. Ribichini (2008)
Head-to-Head Comparison of Sirolimus- and Paclitaxel-Eluting Stent in the Same Diabetic Patient With Multiple Coronary Artery LesionsDiabetes Care, 31
Di Lorenzo (2005)
Paclitaxel and sirolimus stent implantation in patients with acute myocardial infarction (Abstract)Circulation, 112
S. Windecker, P. Serruys, Simon Wandel, P. Buszman, Stanisław Trznadel, A. Linke, K. Lenk, T. Ischinger, V. Klauss, F. Eberli, R. Corti, W. Wijns, M. Morice, C. Mario, S. Davies, R. Geuns, P. Eerdmans, G. Es, B. Meier, P. Jüni (2008)
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trialThe Lancet, 372
J. Goy, J. Stauffer, M. Siegenthaler, A. Benoît, C. Seydoux (2005)
A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trial.Journal of the American College of Cardiology, 45 2
G. Stone, S. Ellis, D. Cox, J. Hermiller, C. O'shaughnessy, J. Mann, M. Turco, R. Caputo, P. Bergin, Joel Greenberg, J. Popma, M. Russell (2004)
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.The New England journal of medicine, 350 3
S. Cook, P. Wenaweser, M. Togni, M. Billinger, Cyrill Morger, C. Seiler, R. Vogel, O. Hess, B. Meier, S. Windecker (2007)
Incomplete Stent Apposition and Very Late Stent Thrombosis After Drug-Eluting Stent ImplantationCirculation, 115
C. Stettler, Simon Wandel, S. Allemann, A. Kastrati, M. Morice, A. Schömig, M. Pfisterer, G. Stone, M. Leon, J. Lezo, J. Goy, Seung‐Jung Park, M. Sabaté, M. Suttorp, H. Kelbaek, C. Spaulding, M. Menichelli, P. Vermeersch, M. Dirksen, P. Červinka, A. Petronio, A. Nordmann, P. Diem, B. Meier, M. Zwahlen, S. Reichenbach, S. Trelle, S. Windecker, P. Jüni (2007)
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysisThe Lancet, 370
M. Ostojić, D. Sagic, B. Beleslin, R. Jung, Z. Perisic, N. Jagic, M. Nedeljković, L. Mangovski, Bratislav Milosavljevic, S. Stojkovic, D. Orlic, Ž. Antonić, V. Miloradovic, Dragan Topić, D. Paunovic (2008)
First clinical comparison of Nobori -Biolimus A9 eluting stents with Cypher- Sirolimus eluting stents: Nobori Core nine months angiographic and one year clinical outcomes.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 3 5
M. Joner, G. Nakazawa, A. Finn, Shawn Quee, Leslie Coleman, Eduardo Acampado, P. Wilson, K. Skorija, Qi Cheng, Xin Xu, H. Gold, F. Kolodgie, R. Virmani (2008)
Endothelial cell recovery between comparator polymer-based drug-eluting stents.Journal of the American College of Cardiology, 52 5
C. Spaulding, J. Daemen, E. Boersma, D. Cutlip, P. Serruys (2007)
A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents.The New England journal of medicine, 356 10
M. Morice, A. Colombo, B. Meier, P. Serruys, C. Tamburino, G. Guagliumi, E. Sousa, H. Stoll (2006)
Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.JAMA, 295 8
A. Galløe, L. Thuesen, H. Kelbaek, P. Thayssen, K. Rasmussen, P. Hansen, N. Bligaard, K. Saunamäki, A. Junker, J. Aarøe, U. Abildgaard, J. Ravkilde, T. Engstrøm, J. Jensen, H. Andersen, H. Bøtker, S. Galatius, S. Kristensen, J. Madsen, L. Krusell, S. Abildstrom, Ghita Stephansen, J. Lassen (2008)
Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.JAMA, 299 4
S. Windecker, A. Remondino, F. Eberli, P. Jüni, L. Räber, P. Wenaweser, M. Togni, M. Billinger, D. Tüller, C. Seiler, M. Roffi, R. Corti, G. Sütsch, W. Maier, T. Lüscher, O. Hess, M. Egger, B. Meier (2005)
Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.The New England journal of medicine, 353 7
M. Morice, H. Bestehorn, D. Carrié, C. Macaya, W. Aengevaeren, W. Wijns, C. Dubois, R. Winter, S. Verheye, S. Hoffmann, O. Pachinger, C. Mario (2006)
Direct stenting of de novo coronary stenoses with tacrolimus-eluting versus carbon-coated carbostents. The randomized JUPITER II trial.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2 1
J. Sousa, M. Costa, A. Sousa, A. Abizaid, A. Seixas, A. Abizaid, F. Feres, L. Mattos, R. Falotico, Judith Jaeger, Ba, J. Popma, P. Serruys, São Paulo, Brazil, Florida-Shands, Johnson, J. Company, N. Warren, Brigham Hospital, J. Boston (2003)
Two-Year Angiographic and Intravascular Ultrasound Follow-Up After Implantation of Sirolimus-Eluting Stents in Human Coronary ArteriesCirculation: Journal of the American Heart Association, 107
G. Rodriguez-Granillo, M. Valgimigli, H. Garcia-Garcia, A. Ong, J. Aoki, C. Mieghem, K. Tsuchida, G. Sianos, E. Mcfadden, W. Giessen, R. Domburg, P. Feyter, P. Serruys (2005)
One-year clinical outcome after coronary stenting of very small vessels using 2.25 mm sirolimus- and paclitaxel-eluting stents: a comparison between the RESEARCH and T-SEARCH registries.The Journal of invasive cardiology, 17 8
Ayala Hezi-Yamit, Carol Sullivan, J. Wong, L. David, Mingfei Chen, Peiwen Cheng, David Shumaker, J. Wilcox, K. Udipi (2009)
Impact of polymer hydrophilicity on biocompatibility: implication for DES polymer design.Journal of biomedical materials research. Part A, 90 1
Ya‐Ling Han, Xiaozeng Wang, Q. Jing, Shou-li Wang, Ying-yan Ma, B. Luan (2006)
[Comparison of Rapamycin and Paclitaxel eluting stent in patients with multi-vessel coronary disease].Zhonghua xin xue guan bing za zhi, 34 2
M. Krucoff, D. Kereiakes, J. Petersen, R. Mehran, V. Hasselblad, A. Lansky, P. Fitzgerald, Jyotsna Garg, M. Turco, C. Simonton, S. Verheye, C. Dubois, R. Gammon, W. Batchelor, C. O'shaughnessy, J. Hermiller, J. Schofer, M. Buchbinder, W. Wijns (2008)
A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study.Journal of the American College of Cardiology, 51 16
A. Petronio, M. Carlo, G. Branchitta, B. Papini, N. Ciabatti, R. Gistri, B. Cortese, G. Gherarducci, A. Barsotti (2007)
Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study.Journal of the American College of Cardiology, 49 5
P. Serruys, P. Ruygrok, J. Neuzner, J. Piek, A. Seth, J. Schofer, G. Richardt, M. Wiemer, D. Carrié, L. Thuesen, E. Boone, K. Miquel-Herbert, J. Daemen (2006)
A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2 3
Moo-Hyun Kim, S. Hong, K. Cha, H. Park, S. Chae, S. Hur, H. Gwon, J. Bae, D. Lim (2008)
Effect of Paclitaxel-eluting versus sirolimus-eluting stents on coronary restenosis in Korean diabetic patients.Journal of interventional cardiology, 21 3
C. Stettler, S. Allemann, Matthias Egger, S. Windecker, B. Meier, P. Diem (2005)
Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trialsHeart, 92
C. Kaiser, H. Rocca, P. Buser, P. Bonetti, S. Osswald, A. Linka, A. Bernheim, A. Zutter, M. Zellweger, L. Grize, M. Pfisterer (2005)
Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET)The Lancet, 366
M. Hamilos, M. Ostojić, B. Beleslin, D. Sagic, Lj Mangovski, S. Stojkovic, M. Nedeljković, D. Orlic, Bratislav Milosavljevic, Dragan Topić, N. Karanovic, W. Wijns (2008)
Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion.Journal of the American College of Cardiology, 51 22
De Lezo (2005)
Drug-eluting stents for complex lesions: Randomized rapamycin versus paclitaxel CORPAL study (Abstract)J Am Coll Cardiol, 45
P. Červinka, M. Costa, D. Angiolillo, R. Spacek, M. Bystroň, M. Kvašňák, J. Veselka, Hitesh Nanda, H. Futamatsu, Kino Futamatsu (2006)
“Head‐to‐head comparison between sirolimus‐eluting and paclitaxel‐eluting stents in patients with complex coronary artery disease: An intravascular ultrasound study”Catheterization and Cardiovascular Interventions, 67
J. Moses, M. Leon, J. Popma, P. Fitzgerald, D. Holmes, C. O'shaughnessy, R. Caputo, D. Kereiakes, David Williams, P. Teirstein, Judith Jaeger, R. Kuntz (2003)
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.The New England journal of medicine, 349 14
M. Billinger, J. Beutler, Keywan Taghetchian, A. Remondino, P. Wenaweser, S. Cook, M. Togni, C. Seiler, C. Stettler, F. Eberli, T. Lüscher, Simon Wandel, P. Jüni, B. Meier, S. Windecker (2008)
Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients.European heart journal, 29 6
J. Sousa, M. Costa, A. Abizaid, F. Feres, A. Seixas, L. Tanajura, L. Mattos, R. Falotico, Judith Jaeger, J. Popma, P. Serruys, A. Sousa (2005)
Four-Year Angiographic and Intravascular Ultrasound Follow-Up of Patients Treated With Sirolimus-Eluting StentsCirculation, 111
M. Togni, S. Eber, J. Widmer, M. Billinger, P. Wenaweser, S. Cook, R. Vogel, C. Seiler, F. Eberli, W. Maier, R. Corti, M. Roffi, T. Lüscher, A. Garachemani, O. Hess, Simon Wandel, B. Meier, P. Jüni, S. Windecker (2007)
Clinical ResearchInterventional CardiologyImpact of Vessel Size on Outcome After Implantation of Sirolimus-Eluting and Paclitaxel-Eluting Stents: A Subgroup Analysis of the SIRTAX TrialJournal of the American College of Cardiology, 50
C. Stettler, S. Allemann, Simon Wandel, A. Kastrati, M. Morice, A. Schömig, M. Pfisterer, G. Stone, M. Leon, J. Lezo, J. Goy, Seung‐Jung Park, M. Sabaté, M. Suttorp, H. Kelbaek, C. Spaulding, M. Menichelli, P. Vermeersch, M. Dirksen, P. Červinka, M. Carlo, A. Erglis, T. Chechi, P. Ortolani, M. Schalij, P. Diem, B. Meier, S. Windecker, P. Jüni (2008)
Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysisThe BMJ, 337
B. Chevalier, P. Serruys, S. Silber, Eulogio García, H. Suryapranata, K. Hauptmann, W. Wijns, G. Schuler, F. Fath-ordoubadi, S. Worthley, L. Thuesen, I. Meredith, Marco Bressers, H. Nagai, D. Paunovic (2007)
Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus(R), paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2 4
Young-Hak Kim, Seong-Wook Park, Seung‐Whan Lee, Duk‐Woo Park, S. Yun, Cheol-Whan Lee, M. Hong, Hyun-Sook Kim, J. Ko, Jae‐Hyeong Park, Jae‐Hwan Lee, Si-Wan Choi, I. Seong, Y. Cho, N. Lee, J. Kim, K. Chun, Seung‐Jung Park (2006)
Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent for Patients With Long Coronary Artery DiseaseCirculation, 114
S. Elezi, A. Dibra, J. Mehilli, J. Pache, R. Wessely, A. Schömig, A. Kastrati (2006)
Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents.Journal of the American College of Cardiology, 48 7
A. Kastrati, A. Dibra, J. Mehilli, S. Mayer, S. Pinieck, J. Pache, J. Dirschinger, A. Schömig (2006)
Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting StentsCirculation, 113
Qi Zhang, Ruiyan Zhang, Jian-sheng Zhang, Jian Hu, Zhen-kun Yang, J. Ni, Yue-hua Fang, Xian Zhang, W. Shen (2006)
One-year clinical outcomes of Chinese sirolimus-eluting stent in the treatment of unselected patients with coronary artery disease.Chinese medical journal, 119 2
G. Stone, M. Midei, W. Newman, Mark Sanz, J. Hermiller, Jerome Williams, Naim Farhat, K. Mahaffey, D. Cutlip, P. Fitzgerald, P. Sood, Xiaolu Su, A. Lansky (2008)
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial.JAMA, 299 16
G. Mintz, N. Weissman (2006)
Intravascular ultrasound in the drug-eluting stent era.Journal of the American College of Cardiology, 48 3
Young-Hak Kim, Seong-Wook Park, Cheol-Whan Lee, M. Hong, H. Gwon, Y. Jang, Myoung Lee, B. Koo, D. Oh, K. Seung, S. Tahk, Junghan Yoon, Seung‐Jung Park (2006)
Comparison of sirolimus‐eluting stent, paclitaxel‐eluting stent, and bare metal stent in the treatment of long coronary lesionsCatheterization and Cardiovascular Interventions, 67
Drug‐eluting stents (DES) have been appraised as breakthrough technology owing to their potent reduction of restenosis, an important nuisance in the quality of life of affected patients, the rare cause of myocardial infarction, and the principal shortcoming compared with coronary artery bypass surgery. First‐generation DES with controlled release of sirolimus or paclitaxel from durable polymers have been attested to reduce the need of target lesion revascularization by 40% to 70% compared with bare metal stents (BMS) requiring treatment of only eight patients (number needed to treat (NNT) 6–10) in order to prevent one revascularization event. The benefit, albeit attenuated, persisted in studies without protocol‐mandated angiographic follow‐up, was particularly pronounced in diabetic patients, and endured during long‐term follow‐up extending to 5 years. While the therapeutic benefit of first‐generation DES has primarily been established as compared against BMS, more recent investigations have concentrated on direct head‐to‐head comparisons between various DES. To date, a number of newer‐generation DES are already in clinical use or under investigation with newly designed stent platforms, improved polymer coatings, and a variety of different drugs. This review will address differences between various DES platforms in terms of angiographic and clinical outcomes. Moreover, the differential outcome of DES in several important patient subgroups will be analyzed.
Journal of Interventional Cardiology – Wiley
Published: Apr 1, 2009
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.